A:

Government regulation lengthens the process for bringing new pharmaceuticals to market and restricts the drugs sector to protect public safety. Governments create incentives for particular behaviors and encourage the development of safe and effective drugs. Pharmaceutical companies are heavily regulated to ensure they are in compliance with federal safety laws. In the United States, the Food and Drug Administration (FDA) ensures that new drugs are rigorously tested for safety, efficacy and minimal side effects.

As a result of this testing, most new drugs are researched and investigated for 10 to 15 years before they are brought to market. Drugs must undergo human trials that are intended to discover potential side effects and treatment efficacy. At any point in the multi-phase testing process, new drugs may fail to show effectiveness or may have unreasonable side effects. If either of these occurs, the company may research it further in the lab at its own expense but will not receive permission to release it to the market until the product yields positive results in human trials.

Throughout this period of research and development, pharmaceutical companies must have dependable sources of financing. Typically, this financing is in the form of either investments and loans or revenue from sales of other products. Government regulation gives a distinct competitive advantage to companies large enough to maintain secure funding. Major drug manufacturers with profitable products already in the market usually do not require the ongoing fundraising and venture capital that startups do.

This process is a significant barrier to entry in the pharmaceutical industry. As a result, mergers and acquisitions (M&As) are common. New companies and larger companies both benefit from mergers. Big companies take advantage of opportunities to acquire profitable new products and small companies benefit from the financial boost and expertise of a large partner. Because of the regulatory expense, companies have a strong incentive to offer support to only the most promising drugs. M&As usually happen only after new drugs begin to show promise in trials.

Some drugs benefit from additional government incentives. Orphan drugs receive special consideration from the FDA in order to encourage pharmaceutical companies to develop treatments for rare diseases. Incentives for the development of orphan drugs include quicker approval time and potential financial assistance for development. Companies are often permitted to charge substantial prices for orphan drugs, making them more profitable than they would be without government intervention. As a result, the development of orphan drugs continues to grow at a faster rate than the development of traditional pharmaceuticals.

Overall, government regulation of the drug sector has resulted in a longer, more-expensive product development process that favors treatments for rare illnesses. All approved drugs have been rigorously tested by the FDA to protect consumers from harmful or ineffective treatments. This process is designed to occur over a long period of time to ensure that only the safest and most effective drugs arrive on the market.

RELATED FAQS
  1. How does the profit margin compare for a generic drug versus a brand name drug?

    Learn how the profit margins compare for generic drugs and brand-name drugs. Brand-name drugs cost three to four times more ... Read Answer >>
  2. Who are Pfizer's (PFE) main competitors?

    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ... Read Answer >>
  3. What metrics are often used to evaluate companies in the drugs sector?

    Learn about some of the equity evaluation metrics that are most frequently used for examining companies in the pharmaceutical ... Read Answer >>
  4. How significantly does government regulation impact the chemicals sector?

    Study the impact of stringent federal regulations on the chemicals sector and learn how industries are impacted by the cost ... Read Answer >>
  5. What are the advantages of a limited government in connection with a capitalist economy?

    Read about the advantages of limited government, why free markets are more efficient and how social cooperation grows where ... Read Answer >>
Related Articles
  1. Insights

    How Pharmaceutical Companies Price Their Drugs

    Learn more about how pharmaceutical companies price drugs, why prices are often very high and why it can be difficult to settle on a suitable price.
  2. Investing

    It's No Accident That Drugs Are Expensive

    Branded drugs are expensive in large part because it's expensive and risky to develop them
  3. Investing

    Evaluating Pharmaceutical Companies

    Learn how to find a healthy pharmaceutical investment in a market full of weak drugs.
  4. Insights

    8 Stages Of New Drug Development

    Understanding biotech data isn't easy. What is a clinical trial, what are the various phases, and why do the results of these trials and applications often create double-digit moves in the price ...
  5. Investing

    Using DCF In Biotech Valuation

    Valuing firms in this sector can seem like a black art, but there is a systematic way to pin a price on potential.
  6. Insights

    The Industry Handbook: Pharma Industry

    Learn about the pharmaceutical industry and discover the forces that influence this highly profitable and dynamic sector.
  7. Investing

    Where Does the US Get Its Supply of Drugs?

    Despite increasing demands for local production, the US imports only a small portion of its drugs.
  8. Investing

    Drug Prices: Name Brands Doubled in Last 5 Years (ESRX)

    Express Scripts' Drug Trends Report, released Monday, revealed that the average price of brand name drugs rose 16.2% in 2015, with over one third of brand name drugs seeing price increases over ...
  9. Investing

    Drug Giants May Benefit From China Drug Inclusion

    Pharma giants may see higher sales as the Chinese government subsidizes expensive prescription drugs.
  10. Investing

    The Risks And Rewards Of Pharma Stocks

    While pharmaceutical stocks have certain risks, big pharma companies have stable cash flows and pricing power, offering opportunities for profit.
RELATED TERMS
  1. New Drug

    A new medication or therapy that has not been used before in ...
  2. New Drug Application (NDA)

    The New Drug Application (NDA) is the formal final step taken ...
  3. Food And Drug Administration - FDA

    The Food and Drug Administration is a government agency that ...
  4. Orange Book

    The Orange Book is a list of drugs that the U.S. Food and Drug ...
  5. Side Effect

    Undesirable symptoms caused by taking a drug or undergoing a ...
  6. Bioequivalence

    Bioequivalence represents the similarity between two drugs that ...
Hot Definitions
  1. Compound Annual Growth Rate - CAGR

    The Compound Annual Growth Rate (CAGR) is the mean annual growth rate of an investment over a specified period of time longer ...
  2. Net Present Value - NPV

    Net Present Value (NPV) is the difference between the present value of cash inflows and the present value of cash outflows ...
  3. Price-Earnings Ratio - P/E Ratio

    The Price-to-Earnings Ratio or P/E ratio is a ratio for valuing a company that measures its current share price relative ...
  4. Internal Rate of Return - IRR

    Internal Rate of Return (IRR) is a metric used in capital budgeting to estimate the profitability of potential investments.
  5. Limit Order

    An order placed with a brokerage to buy or sell a set number of shares at a specified price or better.
  6. Current Ratio

    The current ratio is a liquidity ratio that measures a company's ability to pay short-term and long-term obligations.
Trading Center